J. Goldman & Co’s Otonomy, Inc. OTIC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-135,000
Closed -$281K 530
2022
Q2
$281K Buy
+135,000
New +$281K 0.01% 303
2021
Q3
Sell
-265,648
Closed -$592K 512
2021
Q2
$592K Sell
265,648
-71,852
-21% -$166K 0.02% 316
2021
Q1
$861K Buy
337,500
+70,217
+26% +$288K 0.03% 316
2020
Q4
$1.73M Sell
267,283
-657,362
-71% -$2.99M 0.09% 203
2020
Q3
$3.75M Buy
924,645
+415,481
+82% +$1.57M 0.25% 122
2020
Q2
$1.84M Sell
509,164
-258,648
-34% -$673K 0.11% 170
2020
Q1
$1.51M Buy
+767,812
New +$2.37M 0.18% 120
2018
Q2
Sell
-156,000
Closed -$655K 483
2018
Q1
$655K Sell
156,000
-117,000
-43% -$637K 0.03% 275
2017
Q4
$1.51M Buy
+273,000
New +$1.19M 0.08% 209

Other funds holding OTIC

J. Goldman & Co's OTIC Position: Q3 2022 in Review

J. Goldman & Co sold out of Otonomy, Inc. (OTIC) in Q3 2022, closing a stake of 135,000 shares — an estimated $281K sold.

J. Goldman & Co first reported a position in OTIC in Q4 2017 and held it in 9 quarters. The position peaked at $3.75M in Q3 2020. 40 funds tracked by Wall St. Rank hold OTIC as of Q3 2022.

  • J. Goldman & Co reported no remaining Otonomy, Inc. position as of Q3 2022 after selling out during the quarter.
  • J. Goldman & Co sold 135,000 Otonomy, Inc. shares in Q3 2022, an estimated $281K.
  • J. Goldman & Co first reported a position in Otonomy, Inc. in Q4 2017 and held it in 9 quarters.
  • J. Goldman & Co's Otonomy, Inc. position peaked at $3.75M in Q3 2020.
  • 40 funds tracked by Wall St. Rank held Otonomy, Inc. as of Q3 2022.

Based on J. Goldman & Co's 13F filing for Q3 2022, filed 14 Nov 2022.